ArtivionAnnounces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT) has announced that it will release its first quarter 2022 financial results on May 5, 2022, after market close. A teleconference and live webcast will follow at 4:30 p.m. ET, hosted by CEO Pat Mackin. Investors can participate in the teleconference by dialing 201-689-8261. A replay will be available post-event. Artivion specializes in cardiac and vascular solutions for aortic diseases, with products available in over 100 countries. For more details, visit www.artivion.com.

Positive

• Artivion's focus on cardiac and vascular surgery positions it well in a substantial market.
• The announcement of a scheduled earnings release indicates transparency and engagement with investors.

Negative

• None.

ATLANTA, April 21, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2022 financial results will be released on Thursday, May 5, 2022 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13728477. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Artivion
D. Ashley Lee                                                
Executive Vice President & 
Chief Financial Officer
Phone: 770-419-3355

Gilmartin Group LLC
Brian Johnston / Lynn Lewis
Phone:  332-895-3222
investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2022-financial-results-301529970.html

SOURCE Artivion, Inc.

FAQ

When will Artivion release its first quarter 2022 financial results?

Artivion will release its first quarter 2022 financial results on May 5, 2022, after market close.

What time is the teleconference for Artivion's financial results?

The teleconference will take place at 4:30 p.m. ET on May 5, 2022.

How can I access the replay of Artivion's teleconference?

The replay can be accessed by calling toll-free 877-660-6853 or 201-612-7415.

Who will host the teleconference for Artivion's financial results?

The teleconference will be hosted by Pat Mackin, Chairman, President, and CEO of Artivion.

Where can I find the details of Artivion's financial results?

The details will be available on the Investors section of Artivion's website.